Q2 earnings drive Suven Life to new 52-week high

Suven Life Sciences  was up as much as 4.4 percent to hit a new 52-week high of Rs 29.50 on Thursday following strong numbers in the July-September quarter of current financial year.

A biopharmaceutical company specialising in drug discovery and development activities in central nervous system reported a growth of 150 percent year-on-year in net profit at Rs 6.5 crore in the quarter. Net sales grew marginally to Rs 50.2 crore in the second quarter from Rs 48 crore in a year ago period.
 
At 11:54 hours IST, the stock was up 3.54 percent to Rs 29.25 amid heavy volumes. Market capitalisation of the company currently stands at Rs 341.44 crore.